# Hypnion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hypnion

- Industry: Pharmaceuticals
- Headquarters: Lexington, US
- Website: www.hypnion.com
- Total disclosed funding: $78M
- Latest round: Series B (Dec 18, 2005)
- Investors on record: 11

## About

Hypnion, Inc. is a neuroscience drug discovery and development company.

## Funding rounds

- Series B, Dec 18, 2005, $20M — Advanced Technology Ventures, Flagship Pioneering, Forward Ventures, Oxford Bioscience Partners, Gimv, SR One, Alexandria Venture Investments, Icon Ventures, MPM BioImpact
- Series B, Mar 17, 2003, $48M — Advanced Technology Ventures, Flagship Pioneering, Forward Ventures, Oxford Bioscience Partners, Gimv, SR One, Coastview Capital, Icon Ventures, MPM BioImpact
- Series A, Oct 9, 2000, $10M — Oxford Bioscience Partners, Gimv, Applied Genetic Technologies Corp.

## Investors

- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series A, Series B
- Gimv (https://capitalatlas.ai/funds/gimv) — Series A, Series B
- Applied Genetic Technologies Corp. — Series A
- Advanced Technology Ventures (https://capitalatlas.ai/funds/advanced-technology-ventures) — Series B
- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series B
- Forward Ventures (https://capitalatlas.ai/funds/forward-ventures) — Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- Coastview Capital (https://capitalatlas.ai/funds/coastview-capital) — Series B
- Icon Ventures (https://capitalatlas.ai/funds/icon-ventures) — Series B
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B